Skip to main content

Patient Search

KaCrole Higgins was diagnosed with breast cancer in 2020. “In May 2020, I found a lump in my breast. I cried. By June, it was diagnosed as breast cancer, triple positive, stage 1A. While getting this cancer diagnosis was devastating, it also became an opportunity. Suddenly, the cancer gave me clarity. It gave me clarity about what was important, what was good in my life, what was toxic in my life, and what I needed to do.” Click below to read more of KaCrole’s story

https://momentum.vicc.org/2022/04/cancer-gave-me-clarity/

If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision.Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change Landon’s life when she was 11 months old, but not to take it — or her eyesight. Click below to learn more about Landon and her story.

https://momentum.vicc.org/2022/04/brighter-outlook/
Displaying 81 - 90 of 197

A Single Arm Phase 2 Trial of Atezolizumab with Sacituzumab Govitecan to Prevent Recurrence in Triple Negative Breast Cancer (ASPRIA)

Breast

Breast
II
Abramson, Vandana
NCT04434040
VICCBRE2056

An Open-label Phase 1b Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors

Multiple Cancer Types

Gynecologic, Liver, Phase I
I
Brown, Alaina
NCT04008797
VICC-DTPHI23106


A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

Multiple Cancer Types

Bladder, Kidney (Renal Cell), Rectal
II
Tan, Alan
NCT03866382
ALLIANCEUROA031702

Non-invasive, Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Miscellaneous

Miscellaneous
Early I
Osmundson, Evan
NCT05996432
VICC-EDMDT23195

Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) versus Fractionated SRS (FSRS) for Intact Brain Metastases

Not Available
III
Cmelak, Anthony
NCT06500455
NRGNEUBN013

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Neuro-Oncology

Neuro-Oncology
II
Mohler, Alexander
NCT05425004
VICC-ITNEU23261

Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)

Kidney (Renal Cell)

Kidney (Renal Cell)
II
Rini, Brian
NCT05361720
VICCURO21103

A Phase 1/3 Study to Evaluate the Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Ruxolitinib, in Treatment-Nave Patients with Myelofibrosis

Multiple Cancer Types

Hematologic, Phase I
I/III
Mohan, Sanjay
NCT04562389
VICCHEMP2130

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants with Myeloproliferative Neoplasms

Not Available
I
Kishtagari, Ashwin
NCT06313593
VICC-DTHEM24055P